Clofarabine and Low-Dose Cytarabine Combination in Relapsed/Refractory Acute Myeloid Leukemia Patients with High Risk Features

leukemia, AML, combination therapy, clofarabine, high risk.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Carlos Vigil, Nusrat Jahan, Oana Paun, Jennifer Weis, Kevin Heckman, Margarida Silverman, Thomas Carter Source Type: research